UNSPSC 51182040: Oxabolone

This classification denotes an anabolic steroid with the molecular formula C26H38O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 51RPF719WE, chemically known as 4-hydroxy-19-nortestosterone but generally known as oxabolone, which bears US NIH Compound Identifier 68952. European Medicines Agency schedules Oxabolone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09481MIG. The term OXABOLONE is an International Non-Proprietary Name.

World Health Organization schedules oxabolone in its Anatomical Therapeutic Chemical (ATC) Classification. As of Q4 2014, OXABOLONE remains the US FDA Preferred Term for this commodity. SMILES: CC12CCC3C(C1CCC2O)CCC4=C(C(=O)CCC34)O.

UNSPSC 51182040 Oxabolone is a Commodity code for a pharmaceutical anabolic steroid used primarily in veterinary medicine. State and local governments procure oxabolone through veterinary supply channels for use in animal care facilities, particularly shelters, public health laboratories, and agricultural extension operations that treat livestock and companion animals. The product appears in procurement activity alongside other pharmaceutical agents for disease treatment, wound healing, and metabolic support in animals under public agency care or oversight.

The recent-opportunities block contains no posted solicitations for oxabolone. Without current procurement activity in the state and local record, no issuing-body mix, geographic concentration, or representative opportunities can be identified from the source.